Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on Immunogenicity of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® Using Accelerated Vaccination Schedule in Adults (Aged Over 18 Years)

NCT03168412 is registered in ClinicalTrials.gov with Xiamen Innovax Biotech Co., Ltd as lead sponsor.

NCT NCT03168412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03168412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on Immunogenicity of Recombinant Hepatitis E Vaccine (Escherichia Coli) Hecolin® Using Accelerated Vaccination Schedule in Adults (Aged Over 18 Years)
Lead sponsor
Xiamen Innovax Biotech Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
May 25, 2017
Completion date
November 28, 2018
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis e